Prognostic Impact of Alpha Fetoprotein at Diagnosis on Overall Survival of Single Small Hepatocellular Carcinomas.

Autor:	Lahmidani N; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., Hamdoun FZ; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., Lahlali M; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., Abid H; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., El Yousfi M; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., Benajah DA; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., El Abkari M; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco., Ibrahimi SA; University Hospital Hassan II, School of Medicine and Pharmacy of Fez, Fez, Morocco.; University Sidi Mohammed Ben Abdallah, Morocco.
Jazyk:	angličtina
Zdroj:	The Gulf journal of oncology [Gulf J Oncolog] 2020 May; Vol. 1 (33), pp. 64-67.
Abstrakt:	Background: Alpha-fetoprotein (AFP) is a serum tumor marker used in the past for surveillance and screening of hepatocellular carcinoma (HCC) in patients with cirrhosis. Its prognostic value is still debated in the literature. The aim of this study was to evaluate the prognostic impact of the AFP rate at diagnosis on the overall survival of patients with a small HCC (<3cm) in patients with cirrhosis. Patients and Methods: Among the 122 patients diagnosed with HCC during the study period, 49 patients had a small HCC at diagnosis, including 40,8% (N 20) patients with a negative AFP (group I) and 59,18% (N 29) with an AFP >10 ng / ml (group II). Both groups of patients were comparable for age and WHO status (World Health Organization). Patient survival was assessed by the Kaplan-Meier method. The survival at 5 years was 35.7% in group 1 vs 12.3% in group 2. The AFP level was identified as an independent prognostic factor of survival. Conclusion: Alpha-fetoprotein serum positivity seems to have prognostic value in patients with single small HCC.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu